University of Hertfordshire

Standard

Estimating the Prevalence of Muscle Wasting, Weakness, and Sarcopenia in Hemodialysis Patients. / Slee, Adrian; McKeaveney, Clare; Adamson, Gary; Davenport, Andrew; Farrington, Ken; Fouque, Denis; Kalanter-Zadeh, Kamyar; Mallett, John; Maxwell, A Peter; Mullan, Robert; Noble, Helen; O'Donoghue, Donal; Porter, Sam; Seres, David S; Sheilds, Joanne; Witham, Miles; Reid, Joanne.

In: Journal of Renal Nutrition, 14.11.2019.

Research output: Contribution to journalArticle

Harvard

Slee, A, McKeaveney, C, Adamson, G, Davenport, A, Farrington, K, Fouque, D, Kalanter-Zadeh, K, Mallett, J, Maxwell, AP, Mullan, R, Noble, H, O'Donoghue, D, Porter, S, Seres, DS, Sheilds, J, Witham, M & Reid, J 2019, 'Estimating the Prevalence of Muscle Wasting, Weakness, and Sarcopenia in Hemodialysis Patients', Journal of Renal Nutrition. https://doi.org/10.1053/j.jrn.2019.09.004

APA

Slee, A., McKeaveney, C., Adamson, G., Davenport, A., Farrington, K., Fouque, D., Kalanter-Zadeh, K., Mallett, J., Maxwell, A. P., Mullan, R., Noble, H., O'Donoghue, D., Porter, S., Seres, D. S., Sheilds, J., Witham, M., & Reid, J. (2019). Estimating the Prevalence of Muscle Wasting, Weakness, and Sarcopenia in Hemodialysis Patients. Journal of Renal Nutrition. https://doi.org/10.1053/j.jrn.2019.09.004

Vancouver

Author

Slee, Adrian ; McKeaveney, Clare ; Adamson, Gary ; Davenport, Andrew ; Farrington, Ken ; Fouque, Denis ; Kalanter-Zadeh, Kamyar ; Mallett, John ; Maxwell, A Peter ; Mullan, Robert ; Noble, Helen ; O'Donoghue, Donal ; Porter, Sam ; Seres, David S ; Sheilds, Joanne ; Witham, Miles ; Reid, Joanne. / Estimating the Prevalence of Muscle Wasting, Weakness, and Sarcopenia in Hemodialysis Patients. In: Journal of Renal Nutrition. 2019.

Bibtex

@article{981532953e8b4d908c4cc011c457e560,
title = "Estimating the Prevalence of Muscle Wasting, Weakness, and Sarcopenia in Hemodialysis Patients",
abstract = "Objectives: Haemodialysis (HD) patients suffer from nutritional problems, which include muscle wasting, weakness, and cachexia, and are associated with poor clinical outcomes. The European Working Group for Sarcopenia in Older People (EWGSOP) and Foundations for the National Institute of Health (FNIH) have developed criteria for the assessment of sarcopenia, including the use of non-invasive techniques such as bioelectrical impedance assessment (BIA), anthropometry, and hand grip strength (HGS) dynamometry. This study investigated the prevalence of muscle wasting, weakness, and sarcopenia using the EWGSOP and FNIH criteria. Methods: BIA was performed in 24 females (f) and 63 males (m) in the post-dialysis period. Total skeletal muscle mass and appendicular skeletal muscle mass were estimated and index values (i.e., muscle mass divided by height 2 [kg/m 2]) were calculated (Total Skeletal Muscle Index (TSMI) and Appendicular Skeletal Muscle Index (ASMI)). Mid-arm circumference and triceps skin-fold thickness were measured and mid-upper arm muscle circumference (MUAMC) calculated. HGS was measured using a standard protocol and Jamar dynamometer. Suggested cut-points for low muscle mass and grip strength were utilized using the EWGSOP and FNIH criteria with prevalence estimated, including sarcopenia. Results: The prevalence varied depending on methodology: low TSMI (moderate and severe sarcopenia combined) was 55% for whole group: 21% (f) and 68% (m). Low ASMI was 32% for whole group: 25% (f) and 35% (m). Low MUAMC was 25% for whole group: 0% (f) and 30% (m). ASMI highly correlated with Body Mass Index (r = 0.78, P <.001) and MUAMC (r = 0.68, P <.001). Muscle weakness was high regardless of cut-points used (50-71% (f); 60-79% (m)). Conclusions: Internationally, this is the first study comparing measures of muscle mass (TSMM and ASMM by BIA and MUAMC) and muscle strength (HGS) using this specific methodology in a hemodialysis population. Future work is required to confirm findings. ",
author = "Adrian Slee and Clare McKeaveney and Gary Adamson and Andrew Davenport and Ken Farrington and Denis Fouque and Kamyar Kalanter-Zadeh and John Mallett and Maxwell, {A Peter} and Robert Mullan and Helen Noble and Donal O'Donoghue and Sam Porter and Seres, {David S} and Joanne Sheilds and Miles Witham and Joanne Reid",
note = "{\textcopyright} 2019 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.",
year = "2019",
month = nov,
day = "14",
doi = "10.1053/j.jrn.2019.09.004",
language = "English",
journal = "Journal of Renal Nutrition",
issn = "1051-2276",
publisher = "W.B. Saunders Ltd",

}

RIS

TY - JOUR

T1 - Estimating the Prevalence of Muscle Wasting, Weakness, and Sarcopenia in Hemodialysis Patients

AU - Slee, Adrian

AU - McKeaveney, Clare

AU - Adamson, Gary

AU - Davenport, Andrew

AU - Farrington, Ken

AU - Fouque, Denis

AU - Kalanter-Zadeh, Kamyar

AU - Mallett, John

AU - Maxwell, A Peter

AU - Mullan, Robert

AU - Noble, Helen

AU - O'Donoghue, Donal

AU - Porter, Sam

AU - Seres, David S

AU - Sheilds, Joanne

AU - Witham, Miles

AU - Reid, Joanne

N1 - © 2019 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

PY - 2019/11/14

Y1 - 2019/11/14

N2 - Objectives: Haemodialysis (HD) patients suffer from nutritional problems, which include muscle wasting, weakness, and cachexia, and are associated with poor clinical outcomes. The European Working Group for Sarcopenia in Older People (EWGSOP) and Foundations for the National Institute of Health (FNIH) have developed criteria for the assessment of sarcopenia, including the use of non-invasive techniques such as bioelectrical impedance assessment (BIA), anthropometry, and hand grip strength (HGS) dynamometry. This study investigated the prevalence of muscle wasting, weakness, and sarcopenia using the EWGSOP and FNIH criteria. Methods: BIA was performed in 24 females (f) and 63 males (m) in the post-dialysis period. Total skeletal muscle mass and appendicular skeletal muscle mass were estimated and index values (i.e., muscle mass divided by height 2 [kg/m 2]) were calculated (Total Skeletal Muscle Index (TSMI) and Appendicular Skeletal Muscle Index (ASMI)). Mid-arm circumference and triceps skin-fold thickness were measured and mid-upper arm muscle circumference (MUAMC) calculated. HGS was measured using a standard protocol and Jamar dynamometer. Suggested cut-points for low muscle mass and grip strength were utilized using the EWGSOP and FNIH criteria with prevalence estimated, including sarcopenia. Results: The prevalence varied depending on methodology: low TSMI (moderate and severe sarcopenia combined) was 55% for whole group: 21% (f) and 68% (m). Low ASMI was 32% for whole group: 25% (f) and 35% (m). Low MUAMC was 25% for whole group: 0% (f) and 30% (m). ASMI highly correlated with Body Mass Index (r = 0.78, P <.001) and MUAMC (r = 0.68, P <.001). Muscle weakness was high regardless of cut-points used (50-71% (f); 60-79% (m)). Conclusions: Internationally, this is the first study comparing measures of muscle mass (TSMM and ASMM by BIA and MUAMC) and muscle strength (HGS) using this specific methodology in a hemodialysis population. Future work is required to confirm findings.

AB - Objectives: Haemodialysis (HD) patients suffer from nutritional problems, which include muscle wasting, weakness, and cachexia, and are associated with poor clinical outcomes. The European Working Group for Sarcopenia in Older People (EWGSOP) and Foundations for the National Institute of Health (FNIH) have developed criteria for the assessment of sarcopenia, including the use of non-invasive techniques such as bioelectrical impedance assessment (BIA), anthropometry, and hand grip strength (HGS) dynamometry. This study investigated the prevalence of muscle wasting, weakness, and sarcopenia using the EWGSOP and FNIH criteria. Methods: BIA was performed in 24 females (f) and 63 males (m) in the post-dialysis period. Total skeletal muscle mass and appendicular skeletal muscle mass were estimated and index values (i.e., muscle mass divided by height 2 [kg/m 2]) were calculated (Total Skeletal Muscle Index (TSMI) and Appendicular Skeletal Muscle Index (ASMI)). Mid-arm circumference and triceps skin-fold thickness were measured and mid-upper arm muscle circumference (MUAMC) calculated. HGS was measured using a standard protocol and Jamar dynamometer. Suggested cut-points for low muscle mass and grip strength were utilized using the EWGSOP and FNIH criteria with prevalence estimated, including sarcopenia. Results: The prevalence varied depending on methodology: low TSMI (moderate and severe sarcopenia combined) was 55% for whole group: 21% (f) and 68% (m). Low ASMI was 32% for whole group: 25% (f) and 35% (m). Low MUAMC was 25% for whole group: 0% (f) and 30% (m). ASMI highly correlated with Body Mass Index (r = 0.78, P <.001) and MUAMC (r = 0.68, P <.001). Muscle weakness was high regardless of cut-points used (50-71% (f); 60-79% (m)). Conclusions: Internationally, this is the first study comparing measures of muscle mass (TSMM and ASMM by BIA and MUAMC) and muscle strength (HGS) using this specific methodology in a hemodialysis population. Future work is required to confirm findings.

UR - http://www.scopus.com/inward/record.url?scp=85075427685&partnerID=8YFLogxK

U2 - 10.1053/j.jrn.2019.09.004

DO - 10.1053/j.jrn.2019.09.004

M3 - Article

C2 - 31734056

JO - Journal of Renal Nutrition

JF - Journal of Renal Nutrition

SN - 1051-2276

ER -